Abstract
Regulatory T-cells (Treg cells) are a specific group of T-cells that maintain immune homeostasis by counteracting the immune responses of conventional T-cells. So far, the therapeutic applications of Treg cells have focused on the treatment of autoimmune diseases, as depletion of Treg cells or Treg-related genes is known to cause autoimmune defects. However, Treg cells can be a potential solution for tissue repair as they can terminate the pro-inflammatory phase and initiate the anti-inflammatory or regenerative phase at the tissue injury site. This review summarizes the known characteristics of Treg cells and lists examples of their therapeutic applications. The use of Treg cells in the treatment of myocardial infarctions, skeletal muscle injuries, and ischemia injuries has revealed their potential as a promising tissue repair method. We have also discussed the limitations and scope of Treg cells in tissue repair.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ardon H, Verbinnen B, Maes W, Beez T, Van Gool S, De Vleeschouwer S (2010) Technical advancement in regulatory T cell isolation and characterization using CD127 expression in patients with malignant glioma treated with autologous dendritic cell vaccination. J Immunol Methods 352(1):169–173. https://doi.org/10.1016/j.jim.2009.10.007
Arnold L, Henry A, Poron F, Baba-Amer Y, Van Rooijen N, Plonquet A, Gherardi RK, Chazaud B (2007) Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exp Med 204(5):1057–1069. https://doi.org/10.1084/jem.20070075
Arpaia N, Green JA, Moltedo B, Arvey A, Hemmers S, Yuan S, Treuting PM, Rudensky AY (2015) A distinct function of regulatory T cells in tissue protection. Cell 162(5):1078–1089. https://doi.org/10.1016/j.cell.2015.08.021
Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F (1999) An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 190(7):995–1004. https://doi.org/10.1084/jem.190.7.995
Awasthi A, Carrier Y, Peron JP, Bettelli E, Kamanaka M, Flavell RA, Kuchroo VK, Oukka M, Weiner HL (2007) A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat Immunol 8(12):1380. https://doi.org/10.1038/ni1541
Bacchetta R, Passerini L, Gambineri E, Dai M, Allan SE, Perroni L, Dagna-Bricarelli F, Sartirana C, Matthes-Martin S, Lawitschka A (2006) Defective regulatory and effector T cell functions in patients with FOXP3 mutations. J Clin Invest 116(6):1713. https://doi.org/10.1172/JCI25112
Banerjee DK, Dhodapkar MV, Matayeva E, Steinman RM, Dhodapkar KM (2006) Expansion of FOXP3 high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients. Blood 108(8):2655–2661. https://doi.org/10.1182/blood-2006-03-011353
Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, Kelly TE, Saulsbury FT, Chance PF, Ochs HD (2001) The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27(1):20. https://doi.org/10.1038/ng.83713
Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441(7090):235. https://doi.org/10.1038/nature04753
Bonomo A, Kehn PJ, Shevach EM (1995) Post-thymectomy autoimmunity: abnormal T-cell homeostasis. Immunol Today 16(2):61–67. https://doi.org/10.1016/0167-5699(95)80089-1
Brunstein CG, Miller JS, Cao Q, McKenna DH, Hippen KL, Curtsinger J, DeFor T, Levine BL, June CH, Rubinstein P (2011) Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood 117(3):1061–1070. https://doi.org/10.1182/blood-2010-07-293795
Burzyn D, Kuswanto W, Kolodin D, Shadrach JL, Cerletti M, Jang Y, Sefik E, Tan TG, Wagers AJ, Benoist C (2013) A special population of regulatory T cells potentiates muscle repair. Cell 155(6):1282–1295. https://doi.org/10.1016/j.cell.2013.10.054
Bystry RS, Aluvihare V, Welch KA, Kallikourdis M, Betz AG (2001) B cells and professional APCs recruit regulatory T cells via CCL4. Nat Immunol 2(12):1126. https://doi.org/10.1038/ni735
Canavan JB, Afzali B, Scottà C, Fazekasova H, Edozie FC, Macdonald TT, Hernandez-Fuentes MP, Lombardi G, Lord GM (2012) A rapid diagnostic test for human regulatory T-cell function to enable regulatory T-cell therapy. Blood 119(8):e57–e66. https://doi.org/10.1182/blood-2011-09-380048
Cao X, Cai SF, Fehniger TA, Song J, Collins LI, Piwnica-Worms DR, Ley TJ (2007) Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance. Immunity 27(4):635–646. https://doi.org/10.1016/j.immuni.2007.08.014
Chazaud B, Sonnet C, Lafuste P, Bassez G, Rimaniol A-C, Poron F, Authier F-J, Dreyfus PA, Gherardi RK (2003) Satellite cells attract monocytes and use macrophages as a support to escape apoptosis and enhance muscle growth. J Cell Biol 163(5):1133–1143. https://doi.org/10.1083/jcb.200212046
Chen W, Jin W, Wahl SM (1998) Engagement of cytotoxic T lymphocyte–associated antigen 4 (CTLA-4) induces transforming growth factor β (TGF-β) production by murine CD4+ T cells. J Exp Med 188(10):1849–1857. https://doi.org/10.1084/jem.188.10.1849
Chen W, Jin W, Hardegen N, K-j L, Li L, Marinos N, McGrady G, Wahl SM (2003) Conversion of peripheral CD4+ CD25− naive T cells to CD4+ CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3. J Exp Med 198(12):1875–1886. https://doi.org/10.1084/jem.20030152
Choo EH, Lee J-H, Park E-H, Park HE, Jung N-C, Kim T-H, Koh Y-S, Kim E, Seung K-B, Park C (2017) Infarcted myocardium-primed dendritic cells improve remodeling and cardiac function after myocardial infarction by modulating the Treg and macrophage polarization. Circulation. https://doi.org/10.1161/CIRCULATIONAHA.116.023106
Collison LW, Workman CJ, Kuo TT, Boyd K, Wang Y, Vignali KM, Cross R, Sehy D, Blumberg RS, Vignali DA (2007) The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450(7169):566. https://doi.org/10.1038/nature06306
Coombes JL, Siddiqui KR, Arancibia-Cárcamo CV, Hall J, Sun C-M, Belkaid Y, Powrie F (2007) A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β–and retinoic acid–dependent mechanism. J Exp Med 204(8):1757–1764. https://doi.org/10.1084/jem.20070590
D’alessio FR, Tsushima K, Aggarwal NR, West EE, Willett MH, Britos MF, Pipeling MR, Brower RG, Tuder RM, McDyer JF (2009) CD4+ CD25+ Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury. J Clin Invest 119(10):2898. https://doi.org/10.1172/JCI36498
Eming SA, Krieg T, Davidson JM (2007) Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol 127(3):514–525. https://doi.org/10.1038/sj.jid.5700701
Ertl G, Frantz S (2005) Healing after myocardial infarction. Cardiovasc Res 66(1):22–32. https://doi.org/10.1016/j.cardiores.2005.01.011
Fantini MC, Becker C, Monteleone G, Pallone F, Galle PR, Neurath MF (2004) Cutting edge: TGF-β induces a regulatory phenotype in CD4+ CD25− T cells through Foxp3 induction and down-regulation of Smad7. J Immunol 172(9):5149–5153. https://doi.org/10.4049/jimmunol.172.9.5149
Faustino L, da Fonseca DM, Takenaka MC, Mirotti L, Florsheim EB, Guereschi MG, Silva JS, Basso AS, Russo M (2013) Regulatory T cells migrate to airways via CCR4 and attenuate the severity of airway allergic inflammation. J Immunol 190(6):2614–2621. https://doi.org/10.4049/jimmunol.1202354
Fontenot JD, Gavin MA, Rudensky AY (2003) Foxp3 programs the development and function of CD4+ CD25+ regulatory T cells. Nat Immunol 4(4):330–336. https://doi.org/10.1038/ni904
Gandolfo MT, Jang HR, Bagnasco SM, Ko G-J, Agreda P, Satpute SR, Crow MT, King LS, Rabb H (2009) Foxp3+ regulatory T cells participate in repair of ischemic acute kidney injury. Kidney Int 76(7):717–729. https://doi.org/10.1038/ki.2009.259
Golovina TN, Mikheeva T, Suhoski MM, Aqui NA, Tai VC, Shan X, Liu R, Balcarcel RR, Fisher N, Levine BL (2008) CD28 costimulation is essential for human T regulatory expansion and function. J Immunol 181(4):2855–2868. https://doi.org/10.4049/jimmunol.181.4.2855
Gordon S, Martinez FO (2010) Alternative activation of macrophages: mechanism and functions. Immunity 32(5):593–604. https://doi.org/10.1016/j.immuni.2010.05.007
Gottschalk RA, Corse E, Allison JP (2012) Expression of Helios in peripherally induced Foxp3+ regulatory T cells. J Immunol 188(3):976–980. https://doi.org/10.4049/jimmunol.1102964
Groux H, O’garra A, Bigler M, Rouleau M (1997) A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389(6652):737. https://doi.org/10.1038/39614
Groux H, Fournier N, Cottrez F (2004) Role of dendritic cells in the generation of regulatory T cells. Semin Immunol 16(2):99–106. https://doi.org/10.1016/j.smim.2003.12.004
Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299(5609):1057–1061. https://doi.org/10.1126/science.1079490
Iellem A, Mariani M, Lang R, Recalde H, Panina-Bordignon P, Sinigaglia F, D’Ambrosio D (2001) Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4+ CD25+ regulatory T cells. J Exp Med 194(6):847–854. https://doi.org/10.1084/jem.194.6.847
Jonuleit H, Schmitt E, Schuler G, Knop J, Enk AH (2000) Induction of interleukin 10–producing, nonproliferating CD4+ T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 192(9):1213–1222. https://doi.org/10.1084/jem.192.9.1213
Jonuleit H, Schmitt E, Steinbrink K, Enk AH (2001) Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol 22(7):394–400. https://doi.org/10.1016/S1471-4906(01)01952-4
Josefowicz SZ, Niec RE, Kim HY, Treuting P, Chinen T, Zheng Y, Umetsu DT, Rudensky AY (2012) Extrathymically generated regulatory T cells control mucosal TH2 inflammation. Nature 482(7385):395. https://doi.org/10.1038/nature10772
Kinsey GR, Li L, Okusa MD (2008) Inflammation in acute kidney injury. Nephron Exp Nephrol 109(4):e102–e107. https://doi.org/10.1159/000142934
Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig MC, von Boehmer H (2005) Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 6(12):1219. https://doi.org/10.1038/ni1265
Lee I, Wang L, Wells AD, Dorf ME, Ozkaynak E, Hancock WW (2005) Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor. J Exp Med 201(7):1037–1044. https://doi.org/10.1084/jem.20041709
Levings MK, Sangregorio R, Galbiati F, Squadrone S, de Waal Malefyt R, Roncarolo M-G (2001) IFN-α and IL-10 induce the differentiation of human type 1 T regulatory cells. J Immunol 166(9):5530–5539. https://doi.org/10.4049/jimmunol.166.9.5530
Li MO, Sanjabi S, Flavell RA (2006) Transforming growth factor-β controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and-independent mechanisms. Immunity 25(3):455–471. https://doi.org/10.1016/j.immuni.2006.07.011
Liesz A, Suri-Payer E, Veltkamp C, Doerr H, Sommer C, Rivest S, Giese T, Veltkamp R (2009) Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat Med 15(2):192–199. https://doi.org/10.1038/nm.1927
Lin CH, Hünig T (2003) Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist. Eur J Immunol 33(3):626–638. https://doi.org/10.1002/eji.200323570
Liu H, Hu B, Xu D, Liew FY (2003) CD4+ CD25+ regulatory T cells cure murine colitis: the role of IL-10, TGF-β, and CTLA4. J Immunol 171(10):5012–5017. https://doi.org/10.4049/jimmunol.171.10.5012
Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, Zhu S, Gottlieb PA, Kapranov P, Gingeras TR, Groth BFS (2006) CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 203(7):1701–1711. https://doi.org/10.1084/jem.20060772
Lühder F, Höglund P, Allison JP, Benoist C, Mathis D (1998) Cytotoxic T lymphocyte–associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes. J Exp Med 187(3):427–432. https://doi.org/10.1084/jem.187.3.427
Mandapathil M, Lang S, Gorelik E, Whiteside TL (2009) Isolation of functional human regulatory T cells (Treg) from the peripheral blood based on the CD39 expression. J Immunol Methods 346(1):55–63. https://doi.org/10.1016/j.jim.2009.05.004
Mantovani A, Biswas SK, Galdiero MR, Sica A, Locati M (2013) Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol 229(2):176–185. https://doi.org/10.1002/path.4133
Martin P, Leibovich SJ (2005) Inflammatory cells during wound repair: the good, the bad and the ugly. Trends Cell Biol 15(11):599–607. https://doi.org/10.1016/j.tcb.2005.09.002
Martín-Gayo E, Sierra-Filardi E, Corbí AL, Toribio ML (2010) Plasmacytoid dendritic cells resident in human thymus drive natural Treg cell development. Blood 115(26):5366–5375. https://doi.org/10.1182/blood-2009-10-248260
Milpied P, Renand A, Bruneau J, Mendes-Da-Cruz DA, Jacquelin S, Asnafi V, Rubio MT, MacIntyre E, Lepelletier Y, Hermine O (2009) Neuropilin-1 is not a marker of human Foxp3+ Treg. Eur J Immunol 39(6):1466–1471. https://doi.org/10.1002/eji.200839040
Nakamura K, Kitani A, Strober W (2001) Cell contact–dependent immunosuppression by CD4+ CD25+ regulatory T cells is mediated by cell surface–bound transforming growth factor β. J Exp Med 194(5):629–644. https://doi.org/10.1084/jem.194.5.629
Ohnmacht C, Pullner A, King SB, Drexler I, Meier S, Brocker T, Voehringer D (2009) Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity. J Exp Med 206(3):549–559. https://doi.org/10.1084/jem.20082394
Oo YH, Weston CJ, Lalor PF, Curbishley SM, Withers DR, Reynolds GM, Shetty S, Harki J, Shaw JC, Eksteen B (2010) Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of regulatory T cells in the inflamed human liver. J Immunol 184(6):2886–2898. https://doi.org/10.4049/jimmunol.0901216
Piccirillo CA, Letterio JJ, Thornton AM, McHugh RS, Mamura M, Mizuhara H, Shevach EM (2002) CD4+ CD25+ regulatory T cells can mediate suppressor function in the absence of transforming growth factor β1 production and responsiveness. J Exp Med 196(2):237–246. https://doi.org/10.1084/jem.20020590
Read S, Malmström V, Powrie F (2000) Cytotoxic T lymphocyte–associated antigen 4 plays an essential role in the function of CD25+ CD4+ regulatory cells that control intestinal inflammation. J Exp Med 192(2):295–302. https://doi.org/10.1084/jem.192.2.295
Rubtsov YP, Rasmussen JP, Chi EY, Fontenot J, Castelli L, Ye X, Treuting P, Siewe L, Roers A, Henderson WR (2008) Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28(4):546–558. https://doi.org/10.1016/j.immuni.2008.02.017
Ruitenberg JJ, Boyce C, Hingorani R, Putnam A, Ghanekar SA (2011) Rapid assessment of in vitro expanded human regulatory T cell function. J Immunol Methods 372(1):95–106. https://doi.org/10.1016/j.jim.2011.07.001
Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155(3):1151–1164
Samstein RM, Josefowicz SZ, Arvey A, Treuting PM, Rudensky AY (2012) Extrathymic generation of regulatory T cells in placental mammals mitigates maternal-fetal conflict. Cell 150(1):29–38. https://doi.org/10.1016/j.cell.2012.05.031
Schmidt-Weber CB, Blaser K (2004) Regulation and role of transforming growth factor-β in immune tolerance induction and inflammation. Curr Opin Immunol 16(6):709–716. https://doi.org/10.1016/j.coi.2004.09.008
Seddon B, Mason D (1999) Regulatory T cells in the control of autoimmunity: the essential role of transforming growth factor β and interleukin 4 in the prevention of autoimmune thyroiditis in rats by peripheral CD4+ CD45RC− cells and CD4+ CD8− thymocytes. J Exp Med 189(2):279–288. https://doi.org/10.1084/jem.189.2.279
Stout RD, Suttles J (2004) Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J Leukoc Biol 76(3):509–513. https://doi.org/10.1189/jlb.0504272
Taams LS, van Amelsfort JM, Tiemessen MM, Jacobs KM, de Jong EC, Akbar AN, Bijlsma JW, Lafeber FP (2005) Modulation of monocyte/macrophage function by human CD4+ CD25+ regulatory T cells. Hum Immunol 66(3):222–230. https://doi.org/10.1016/j.humimm.2004.12.006
Takahashi T, Tagami T, Yamazaki S, Uede T, Shimizu J, Sakaguchi N, Mak TW, Sakaguchi S (2000) Immunologic self-tolerance maintained by CD25+ CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte–associated antigen 4. J Exp Med 192(2):303–310
Tang Q, Lee K (2012) Regulatory T-cell therapy for transplantation: how many cells do we need? Curr Opin Organ Transplant 17(4):349–354. https://doi.org/10.1097/MOT.0b013e328355a992
Tang Q, Boden EK, Henriksen KJ, Bour-Jordan H, Bi M, Bluestone JA (2004) Distinct roles of CTLA-4 and TGF-β in CD4+ CD25+ regulatory T cell function. Eur J Immunol 34(11):2996–3005. https://doi.org/10.1002/eji.200425143
Thornton AM, Shevach EM (1998) CD4+ CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 188(2):287–296
Thornton AM, Korty PE, Tran DQ, Wohlfert EA, Murray PE, Belkaid Y, Shevach EM (2010) Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J Immunol 184(7):3433–3441. https://doi.org/10.4049/jimmunol.0904028
Tiemessen MM, Jagger AL, Evans HG, van Herwijnen MJ, John S, Taams LS (2007) CD4+ CD25+ Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages. Proc Natl Acad Sci 104(49):19446–19451. https://doi.org/10.1073/pnas.0706832104
Tivol EA, Borriello F, Schweitzer AN, Lynch WP, Bluestone JA, Sharpe AH (1995) Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3(5):541–547
Trzonkowski P, Bieniaszewska M, Juścińska J, Dobyszuk A, Krzystyniak A, Marek N, Myśliwska J, Hellmann A (2009) First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+ CD25+ CD127− T regulatory cells. Clin Immunol 133(1):22–26. https://doi.org/10.1016/j.clim.2009.06.001
Vieira PL, Christensen JR, Minaee S, O’Neill EJ, Barrat FJ, Boonstra A, Barthlott T, Stockinger B, Wraith DC, O’Garra A (2004) IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+ CD25+ regulatory T cells. J Immunol 172(10):5986–5993. https://doi.org/10.4049/jimmunol.172.10.5986
Wakkach A, Cottrez F, Groux H (2001) Differentiation of regulatory T cells 1 is induced by CD2 costimulation. J Immunol 167(6):3107–3113. https://doi.org/10.4049/jimmunol.167.6.3107
Watanabe N, Yi-Hong W, Lee HK, Ito T (2005) Hassall’s corpuscles instruct dendritic cells to induce CD4+ CD25+ regulatory T cells in human thymus. Nature 436(7054):1181. https://doi.org/10.1038/nature03886
Waterhouse P, Penninger JM, Timms E, Wakeham A, Shahinian A, Lee KP, Thompson CB, Griesser H, Mak TW (1995) Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270:985–988
Weiner HL (2001) Induction and mechanism of action of transforming growth factor-β-secreting Th3 regulatory cells. Immunol Rev 182(1):207–214. https://doi.org/10.1034/j.1600-065X.2001.1820117.x
Weiner M, Howard L (1997) Oral tolerance for the treatment of autoimmune diseases. Annu Rev Med 48(1):341–351. https://doi.org/10.1146/annurev.med.48.1.341
Weirather J, Hofmann U, Beyersdorf N, Ramos GC, Vogel B, Frey A, Ertl G, Kerkau T, Frantz S (2014) Foxp3+ CD4+ T cells improve healing after myocardial infarction by modulating monocyte/macrophage differentiation. Circ Res. https://doi.org/10.1161/CIRCRESAHA.115.303895
Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T, Miyara M, Fehervari Z, Nomura T, Sakaguchi S (2008) CTLA-4 control over Foxp3+ regulatory T cell function. Science 322(5899):271–275. https://doi.org/10.1126/science.1160062
Yadav M, Bluestone JA, Stephan S (2013) Peripherally induced tregs–role in immune homeostasis and autoimmunity. Front Immunol 4(232):1–12. https://doi.org/10.3389/fimmu.2013.00232
Yamagiwa S, Gray JD, Hashimoto S, Horwitz DA (2001) A role for TGF-β in the generation and expansion of CD4+ CD25+ regulatory T cells from human peripheral blood. J Immunol 166(12):7282–7289. https://doi.org/10.4049/jimmunol.166.12.7282
Yamazaki S, Bonito AJ, Spisek R, Dhodapkar M, Inaba K, Steinman RM (2007) Dendritic cells are specialized accessory cells along with TGF-β for the differentiation of Foxp3+ CD4+ regulatory T cells from peripheral Foxp3− precursors. Blood 110(13):4293–4302. https://doi.org/10.1182/blood-2007-05-088831
You S, Belghith M, Cobbold S, Alyanakian M-A, Gouarin C, Barriot S, Garcia C, Waldmann H, Bach J-F, Chatenoud L (2005) Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T-cells. Diabetes 54(5):1415–1422. https://doi.org/10.2337/diabetes.54.5.1415
Youhai-Chen VKK, Inobe J-i, Hafler DA, Weiner HL (1994) Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265:1237. https://doi.org/10.1126/science.7520605
Zhang X, Izikson L, Liu L, Weiner HL (2001) Activation of CD25+ CD4+ regulatory T cells by oral antigen administration. J Immunol 167(8):4245–4253. https://doi.org/10.4049/jimmunol.167.8.4245
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Hong, J., Kim, BS. (2018). Regulatory T Cell-Mediated Tissue Repair. In: Noh, I. (eds) Biomimetic Medical Materials. Advances in Experimental Medicine and Biology, vol 1064. Springer, Singapore. https://doi.org/10.1007/978-981-13-0445-3_14
Download citation
DOI: https://doi.org/10.1007/978-981-13-0445-3_14
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-0444-6
Online ISBN: 978-981-13-0445-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)